Leiden University Scholarly Publications

Cancer-specific T helper shared and neo-epitopes uncovered by expression of the MHC class II master regulator CIITA

Cancer-specific T helper shared and neo-epitopes uncovered by expression of the MHC class II master regulator CIITA

Lipid A analog CRX-527 conjugated to synthetic peptides enhances vaccination efficacy and tumor control

Lipid A analog CRX-527 conjugated to synthetic peptides enhances vaccination efficacy and tumor control

Pyroptosis-inducing active caspase-1 as a genetic adjuvant in anti-cancer DNA vaccination

Cancer vaccine strategies to improve immunotherapy

Multivalent, stabilized mannose-6-phosphates for the targeted delivery of toll-like receptor ligands and peptide antigens

Self-adjuvanting cancer vaccines from conjugation-ready lipid A analogues and synthetic long peptides

Self-adjuvanting cancer vaccines from conjugation-ready lipid A analogues and synthetic long peptides

Multivalent, stabilized mannose-6-phosphates for the targeted delivery of toll-like receptor ligands and peptide antigens

Identification of a neo-epitope dominating endogenous CD8 T cell responses to MC-38 colorectal cancer

Cationic synthetic long peptides-loaded nanogels: An efficient therapeutic vaccine formulation for induction of T-cell responses

A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control

Peptides conjugated to 2-alkoxy-8-oxo-adenine as potential synthetic vaccines triggering TLR7

Dual Synthetic Peptide Conjugate Vaccine Simultaneously Triggers TLR2 and NOD2 and Activates Human Dendritic Cells

Peptides conjugated to 2-alkoxy-8-oxo-adenine as potential synthetic vaccines triggering TLR7

Dual Synthetic Peptide Conjugate Vaccine Simultaneously Triggers TLR2 and NOD2 and Activates Human Dendritic Cells.

Approaches to Improve Chemically Defined Synthetic Peptide Vaccines

Approaches to Improve Chemically Defined Synthetic Peptide Vaccines